NASDAQ:RARX - Ra Pharmaceuticals SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$22.57 -1.93 (-7.88 %)
(As of 05/20/2019 04:00 PM ET)
Previous Close$24.50
Today's Range$22.49 - $24.62
52-Week Range$5.86 - $27.68
Volume364,900 shs
Average Volume437,591 shs
Market Capitalization$954.78 million
P/E RatioN/A
Dividend YieldN/A
Beta0.79

SEC Filings

Ra Pharmaceuticals (NASDAQ:RARX) SEC Filings

DateFilerForm TypeView
05/09/2019
4:14 PM
Ra Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
05/09/2019
4:11 PM
Ra Pharmaceuticals (Filer)
Form 424B5
View Filing
05/09/2019
3:42 PM
Ra Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/09/2019
3:08 PM
Ra Pharmaceuticals (Filer)
Form S-3ASR
View Filing
05/09/2019
5:27 AM
Ra Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
04/26/2019
2:47 PM
Ra Pharmaceuticals (Filer)
Form DEFA14A
View Filing
04/26/2019
2:42 PM
Ra Pharmaceuticals (Filer)
Form DEF 14A
View Filing
04/18/2019
4:55 PM
King John C (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/08/2019
3:51 PM
MORGENTHALER VENTURE PARTNERS IX LP (Filed by)
Ra Pharmaceuticals (Subject)
Form SC 13D/A
View Filing
03/07/2019
6:20 AM
Ra Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/06/2019
5:06 PM
Ra Pharmaceuticals (Issuer)
Ricardo Alonso (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
02/05/2019
6:40 PM
King John C (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/05/2019
6:39 PM
Lubner David Charles (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/05/2019
6:39 PM
Ra Pharmaceuticals (Issuer)
Read Simon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/05/2019
6:38 PM
Farzaneh-Far Ramin (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/05/2019
6:38 PM
Ra Pharmaceuticals (Issuer)
Treco Douglas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/22/2019
3:54 PM
MORGENTHALER VENTURE PARTNERS IX LP (Filed by)
Ra Pharmaceuticals (Subject)
Form SC 13D/A
View Filing
01/07/2019
4:05 PM
MORGENTHALER VENTURE PARTNERS IX LP (Filed by)
Ra Pharmaceuticals (Subject)
Form SC 13D/A
View Filing
12/14/2018
5:22 PM
BARRIS PETER J (Reporting)
BASKETT FOREST (Reporting)
KERINS PATRICK J (Reporting)
MOTT DAVID M (Reporting)
NEA 13 GP, Ltd (Reporting)
NEA Partners 13, Limited Partnership (Reporting)
NEW ENTERPRISE ASSOCIATES 13 LP (Reporting)
Ra Pharmaceuticals (Issuer)
SANDELL SCOTT D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/14/2018
5:17 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, LLC (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/14/2018
5:14 PM
Ra Pharmaceuticals (Issuer)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/14/2018
5:03 AM
Ra Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/12/2018
4:31 PM
Ra Pharmaceuticals (Filer)
Form 424B5
View Filing
12/11/2018
4:24 PM
Ra Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/10/2018
3:15 PM
Ra Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/15/2018
3:34 PM
Cumbo Alexander (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/15/2018
3:32 PM
Cumbo Alexander (Reporting)
Ra Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
11/15/2018
3:30 PM
Ra Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/07/2018
3:12 PM
Ra Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
11/01/2018
7:01 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, LLC (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/25/2018
8:20 AM
Brennan Aoife (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/25/2018
8:19 AM
Brennan Aoife (Reporting)
Ra Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/25/2018
8:16 AM
Ra Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/08/2018
6:00 AM
Ra Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
07/02/2018
3:30 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, LLC (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/02/2018
3:22 PM
Mathers Edward T (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/02/2018
6:25 AM
Heft Robert (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/02/2018
6:25 AM
PEARSON TIMOTHY R (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/02/2018
6:25 AM
Bisgaard Peter (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/02/2018
6:24 AM
Ra Pharmaceuticals (Issuer)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/29/2018
7:13 AM
Ra Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/07/2018
7:19 AM
Ra Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/09/2018
4:28 PM
Ra Pharmaceuticals (Filer)
Form 424B5
View Filing
05/09/2018
4:25 PM
Ra Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/09/2018
3:36 PM
Ra Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
05/09/2018
3:09 PM
Ra Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/07/2018
4:08 PM
Ra Pharmaceuticals (Filer)
Form DEFR14A
View Filing
05/02/2018
3:42 PM
King John C (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/27/2018
3:41 PM
Ra Pharmaceuticals (Filer)
Form DEFA14A
View Filing
04/27/2018
3:38 PM
Ra Pharmaceuticals (Filer)
Form DEF 14A
View Filing
04/23/2018
7:58 PM
King John C (Reporting)
Ra Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
03/14/2018
3:06 PM
Ra Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/02/2018
3:07 PM
Novo Holdings A/S (Filed by)
Ra Pharmaceuticals (Subject)
Form SC 13D/A
View Filing
02/27/2018
9:27 AM
NEW ENTERPRISE ASSOCIATES 13 LP (Filed by)
Ra Pharmaceuticals (Subject)
Form SC 13D/A
View Filing
02/26/2018
10:48 AM
Novo Holdings A/S (Filed by)
Ra Pharmaceuticals (Subject)
Form SC 13D/A
View Filing
02/21/2018
3:19 PM
BARRETT M JAMES (Reporting)
BARRIS PETER J (Reporting)
BASKETT FOREST (Reporting)
KERINS PATRICK J (Reporting)
MOTT DAVID M (Reporting)
NEA 13 GP, Ltd (Reporting)
NEA Partners 13, Limited Partnership (Reporting)
NEW ENTERPRISE ASSOCIATES 13 LP (Reporting)
Ra Pharmaceuticals (Issuer)
SANDELL SCOTT D (Reporting)
Viswanathan Ravi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/16/2018
3:42 PM
Ra Pharmaceuticals (Issuer)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/16/2018
3:42 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, LLC (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/16/2018
3:42 PM
RA CAPITAL MANAGEMENT, LLC (Filed by)
Ra Pharmaceuticals (Subject)
Form SC 13D/A
View Filing
02/13/2018
8:52 PM
Ra Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/13/2018
8:51 PM
Ra Pharmaceuticals (Filer)
Form 424B5
View Filing
02/05/2018
8:46 PM
Farzaneh-Far Ramin (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/05/2018
8:46 PM
Ra Pharmaceuticals (Issuer)
Read Simon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/05/2018
8:46 PM
Lubner David Charles (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/05/2018
8:45 PM
Ra Pharmaceuticals (Issuer)
Treco Douglas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/02/2018
3:06 PM
Novartis Bioventures Ltd (Filed by)
Ra Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
12/08/2017
4:18 PM
Ra Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
This page was last updated on 5/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel